CVRx (CVRX) Change in Account Payables (2020 - 2026)
CVRx (CVRX) posted Change in Account Payables of $875000.0 for Q2 2026, up 204.92% on a QoQ basis from -$834000.0 in Q1 2026, and up 211.39% year-over-year from $281000.0 in Q2 2025.
Powered by 
Analysis
CVRx (CVRX) Change in Account Payables (2020 - 2026) Analysis & Trends
CVRx has reported Change in Account Payables for 7 years, with the latest figure at $875000.0 in Q2 2026.
- On a quarterly basis, Change in Account Payables rose 211.39% year-over-year to $875000.0 in Q2 2026; TTM through Jun 2026 was $842000.0, a 273.97% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 79.23% from the prior year.
- Change in Account Payables was $875000.0 for Q2 2026 at CVRx, up from -$834000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $1.1 million in Q1 2022, with the low at -$1.8 million in Q3 2023.
- Average Change in Account Payables over 5 years is $186888.9, with a median of $362000.0 recorded in 2022.
- The largest YoY upside for Change in Account Payables was 1529.03% in 2022 against a maximum downside of 2536.59% in 2022.
- Over 5 years, Change in Account Payables stood at $443000.0 in 2022, then jumped by 69.53% to $751000.0 in 2023, then plunged by 192.41% to -$694000.0 in 2024, then jumped by 129.54% to $205000.0 in 2025, then jumped by 326.83% to $875000.0 in 2026.
- The last three Change in Account Payables figures came in at $875000.0 (Q2 2026), -$834000.0 (Q1 2026), and $205000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 71.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 4.30 Mn |
| 10 | CVRx | 75.57 Mn | 10.98 Mn | 13.72 Mn | 875,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 875,000.00 |
| Mar 31, 2026 | -834,000.00 |
| Dec 31, 2025 | 205,000.00 |
| Sep 30, 2025 | 596,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Mar 31, 2025 | 169,000.00 |
| Dec 31, 2024 | -694,000.00 |
| Sep 30, 2024 | -240,000.00 |
| Jun 30, 2024 | 908,000.00 |
| Mar 31, 2024 | 724,000.00 |
| Dec 31, 2023 | 751,000.00 |
| Sep 30, 2023 | -1.80 Mn |
| Jun 30, 2023 | 937,000.00 |
| Mar 31, 2023 | 277,000.00 |
| Dec 31, 2022 | 443,000.00 |
| Sep 30, 2022 | 668,000.00 |
| Jun 30, 2022 | -999,000.00 |
| Mar 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | -31,000.00 |
| Sep 30, 2021 | -347,000.00 |